Building on success: the sustainability and national feasibility of a community pharmacy intervention to improve the management of asthma

Not Applicable

Completed

• Conditions: Asthma; Respiratory - Asthma

• Registration Number: ACTRN12609000196246
• Lead Sponsor: nit for Medication Outcomes Research and Education, School of Pharmacy, University of Tasmania

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-04-20
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Participants (patients with asthma, community pharmacusts and general practitioners) must have been involved in the previous intervention study.

Exclusion Criteria

Participants who are deceased, patients who do not have a curent diagnosis of asthma, community pharmacists and GPs who no longer practice at least half-time.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasiblity - Qualitative analysis of patients, community pharmacists and general practitioners to identify common themes regarding the barriers and enables of a national intervention program. Interviews will be conducted face-to-face, on a one-to-one basis, and will be semi-structured.[The interviews will take place in March 2009.];Sustainability - Quantitative analysis of the patients' asthma medcations, in particular, the ratio of dispensed inhaled corticosteroids to dispensed short-acting beta-2-agonists. The data will be collected by retrospective interrogation of pharmacy dispensing data, in all previously participating pharmacies. All data was de-identified originally, but uniquely coded to enable paired data analysis in the future.[The quantitive data will be collected in November 2008.]

Secondary Outcome Measures

Name	Time	Method
/A[N/A]